Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spectrum Disease Neuromyelitis Optica”

154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 154 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05346354
What this trial is testing

Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 12
Not applicableUnknownNCT06068829
What this trial is testing

Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Feng Jinzhou 80
Early research (Phase 1)Not Yet RecruitingNCT07676266
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder+3 more
The Affiliated Hospital of Qingdao University 18
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)Rheumatoid Arthritis (RA)+6 more
Polina Stepensky 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07685678
What this trial is testing

Study on Efficacy Evaluation of Ripertamab in the Treatment of Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disease (NMOSD)Ripertamab
Zhongming Qiu 20
Very early researchNot Yet RecruitingNCT07592754
What this trial is testing

The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.

Who this might be right for
Neuromyelitis Optica Spectrum Disease (NMOSD)
Chinese PLA General Hospital 18
Not applicableUnknownNCT06118398
What this trial is testing

Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis OpticaEfgartigimod
Feng Jinzhou 24
Not applicableStudy completedNCT07164924
What this trial is testing

Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisordersFertility
University Hospital, Clermont-Ferrand 800
Large-scale testing (Phase 3)Not Yet RecruitingNCT07132398
What this trial is testing

Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD

Who this might be right for
Neuromyelitis Optica (NMO)Neuromyelitis Optica Spectrum Disorders (NMOSD)
Tianjin Medical University General Hospital 170
Testing effectiveness (Phase 2)Study completedNCT05551598
What this trial is testing

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 46
Large-scale testing (Phase 3)Ended earlyNCT04155424
What this trial is testing

The Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 5
Large-scale testing (Phase 3)Looking for participantsNCT07557420
What this trial is testing

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMOSDNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 19
Not applicableStudy completedNCT03766347
What this trial is testing

Pediatric NMOSD Observational Study

Who this might be right for
Neuromyelitis OpticaNMO Spectrum Disorder
Mayo Clinic 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT07818356
What this trial is testing

Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial

Who this might be right for
VaccineVaricella-zoster VirusMultiple Sclerosis+1 more
University Hospital, Toulouse 160
Large-scale testing (Phase 3)Study completedNCT02073279
What this trial is testing

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica (NMO)NMO Spectrum Disorder (NMOSD)
Hoffmann-La Roche 95
Large-scale testing (Phase 3)Looking for participantsNCT06413654
What this trial is testing

A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Shanghai Jiaolian Drug Research and Development Co., Ltd 132
Not applicableUnknownNCT05605951
What this trial is testing

Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve

Who this might be right for
Demyelinating DiseasesMultiple SclerosisNeuromyelitis Optica Spectrum Disorder Attack+2 more
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul 200
Early research (Phase 1)Study completedNCT04227470
What this trial is testing

HBM9161 in NMOSD Patients

Who this might be right for
NMO Spectrum Disorder
Harbour BioMed (Guangzhou) Co. Ltd. 9
Early research (Phase 1)Not Yet RecruitingNCT07573332
What this trial is testing

A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients

Who this might be right for
AQP4+ NMOSD
University of Texas Southwestern Medical Center 5
Not applicableLooking for participantsNCT07202494
What this trial is testing

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisordersMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)+7 more
Assistance Publique Hopitaux De Marseille 700
Next Page